Trials / Sponsors / IntraBio Inc
IntraBio Inc
Industry · 7 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Pivotal Study of N-acetyl-L-leucine for CACNA1A CACNA1A, Spinocerebellar Ataxia Type 6, Episodic Ataxia Type 2 | Phase 3 | 2026-09-01 |
| Active Not Recruiting | A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T) Ataxia-Telangiectasia, Ataxia-Telangiectasia (A-T) | Phase 3 | 2025-03-18 |
| Recruiting | A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C Niemann-Pick Disease, Type C | Phase 3 | 2022-06-30 |
| Terminated | N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T) Ataxia Telangiectasia | Phase 2 | 2020-01-08 |
| Completed | N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC) Niemann-Pick Disease, Type C | Phase 2 | 2019-09-04 |
| Completed | N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease) GM2 Gangliosidosis, Tay-Sachs Disease, Sandhoff Disease | Phase 2 | 2019-06-07 |
| Available | Expanded Access Program (EAP) of Levacetylleucine for Ataxia-Telangiectasia (A-T) Ataxia-Telangiectasia (A-T) | — | — |